Cargando…
Desmocollin-2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma via the ERK/c-MYC signaling pathway
Hepatocellular carcinoma (HCC) is one of the most common cancers around the world with a poor prognosis. The main reason for poor prognosis is early stage HCC is inconspicuous so it is difficult to detect and effective treatment strategies are lacking for advanced HCC. In this context, novel molecul...
Autores principales: | He, Bo, Guo, Li, Hu, Youwen, Huang, Hongyan, Wan, Lijun, Xu, Kedong, Wang, Fenfen, Wen, Zhili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699757/ https://www.ncbi.nlm.nih.gov/pubmed/36367775 http://dx.doi.org/10.18632/aging.204370 |
Ejemplares similares
-
Desmocollin switching in colorectal cancer
por: Khan, K, et al.
Publicado: (2006) -
Novel Bradykinin Receptor Inhibitors Inhibit Proliferation and Promote the Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the ERK Pathway
por: Wang, Yiou, et al.
Publicado: (2021) -
Significance of anti‐desmocollin autoantibodies in pemphigus
por: Ishii, Norito
Publicado: (2022) -
Plakoglobin as a Regulator of Desmocollin Gene Expression
por: Tokonzaba, Etienne, et al.
Publicado: (2013) -
Anti-Desmocollin Autoantibodies in Autoimmune Blistering Diseases
por: Bosch-Amate, Xavier, et al.
Publicado: (2021)